Intellia Therapeutics NTLA Change in AR
Change in AR at other companies
Other financials
Where this comes from
Reported directly by Intellia Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.
The official record: Intellia Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Intellia Therapeutics's change in ar.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Intellia Therapeutics's change in AR?
- Intellia Therapeutics (NTLA) reported change in AR of -$337K in Q1 2026.
- How has Intellia Therapeutics's change in AR changed year-over-year?
- Intellia Therapeutics's change in AR decreased by 117.0% year-over-year, from $1.99M to -$337K.
- What does change in AR mean?
- Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.